1.16

1.69% -0.02

After Hours: 1.17 0.01 +0.86%

Revelation Biosciences Inc (REVB)

Overview News Price History Financials Discussions Forecast Stock Split

Revelation Biosciences Inc stock is traded at $1.16, with a volume of 22,159. It is down -1.69% in the last 24 hours and up +18.37% over the past month. Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Previous Close:

$1.18

Open:

$1.18

24h Volume:

22,159

Relative Volume:

0.37

Market Cap:

$4.53M

Revenue:

Net Income/Loss:

$-9.87M

P/E Ratio:

-0.0294

EPS:

-39.4678

Net Cash Flow:

$-8.76M

1W Performance:

+17.54%

1M Performance:

+18.37%

6M Performance:

-68.96%

1Y Performance:

-90.17%

1-Day Range:

$1.155

$1.20

1-Week Range:

$0.97

$1.225

52-Week Range:

$0.875

$12.88

Revelation Biosciences Inc Stock (REVB) Company Profile

Name

Revelation Biosciences Inc

Sector

Healthcare (1089)

Industry

Biotechnology (603)

Phone

650-800-3717

Address

4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

REVB's Discussions on Twitter

Compare REVB vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
REVB Revelation Biosciences Inc	1.16	4.61M	0	-9.87M	-8.76M	-39.47
VRTX Vertex Pharmaceuticals Inc	480.50	123.26B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	672.15	70.94B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	846.19	53.84B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	180.39	39.58B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	272.67	35.71B	4.29B	577.22M	641.34M	4.2086

Revelation Biosciences Inc Stock (REVB) Latest News

Jul 13, 2026

Revelation Biosciences Adopts Stockholder Rights Plan to Protect Investors and Maximize Value - Minichart

Jul 13, 2026

Revelation Biosciences Adopts Stockholder Rights Protection Plan - TipRanks

Jul 13, 2026

Why Is Revelation Biosciences (NASDAQ:REVB) in Focus Today? - Kalkine Media

Jul 13, 2026

Jul 10, 2026

Revelation Biosciences Announces Adoption of Stockholder Rights Plan - ACCESS Newswire

Jul 10, 2026

New plan lets Revelation investors buy discounted shares if a buyer crosses 10% - Stock Titan

Jul 10, 2026

Jul 07, 2026

Revelation Biosciences (REVB) Hovers Near Support Amid Modest DeclineBollinger Expansion - dars.gov.et

Jul 07, 2026

Jul 04, 2026

REVB Q1 2026 Earnings: EPS Misses Estimates Significantly Amid No Revenue; Stock Rises 3.85%Earnings Cycle Outlook - DonanımHaber

Jul 04, 2026

Jul 03, 2026

Revelation Biosciences, Inc. Warrant 2022-10.01.27 on Revelatn Biosci Financial Disclosures & SEC Filings - TradingView

Jul 03, 2026

Jun 30, 2026

Price to sales forward of Revelation Biosciences, Inc. – NASDAQ:REVB - TradingView

Jun 30, 2026

Price to earnings forward of Revelation Biosciences, Inc. – NASDAQ:REVBW - TradingView

Jun 30, 2026